Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome by Andreas Reiter https://t.co/XaaDNRFKXt
1,384 followers
5,925 followers
RT @FrontImmunol: New Research: Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinoph…
18,077 followers
Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome: Background, Current standard-of-care treatments for hypereosinophilic syndrome (HES) include oral.#immunology… https://t.co/Oki2t5C59
33,182 followers
New Research: Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome: Background Current standard-of-care treatments for hypereosinophilic syndrome (HES) include oral… https://t.co/mdvOuzei